scout

Lakshmi Nayak, MD
Lakshmi Nayak, MD, of Dana-Farber Cancer Institute

Lakshmi Nayak, MD, is the director of the Center for Central Nervous System Lymphoma and a senior physician at Dana-Farber Cancer Institute. She is also an associate professor of neurology at Harvard Medical School.

Articles by Lakshmi Nayak, MD

Tirabrutinib for the Treatment of Relapsed or Refractory Primary Central Nervous System Lymphoma: Efficacy and Safety From the Phase II PROSPECT Study

ByLakshmi Nayak, MD

Dr. Lakshmi Nayak presents results from the Phase II PROSPECT study, demonstrating that tirabrutinib monotherapy yields a 66.7% overall response rate and a manageable safety profile in patients with relapsed or refractory primary central nervous system lymphoma, supporting its potential as an effective treatment option in this challenging population.

Latest Updated Articles